- Home
- NVCR vs PZZA Comparison
NVCR vs PZZA Comparison
Compare NVCR & PZZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- PZZA
- Stock Information
- Founded
- NVCR 2000
- PZZA 1984
- Country
- NVCR Switzerland
- PZZA United States
- Employees
- NVCR N/A
- PZZA N/A
- Industry
- NVCR Medical/Dental Instruments
- PZZA Restaurants
- Sector
- NVCR Health Care
- PZZA Consumer Discretionary
- Exchange
- NVCR Nasdaq
- PZZA Nasdaq
- Market Cap
- NVCR 1.3B
- PZZA 1.3B
- IPO Year
- NVCR 2015
- PZZA 1993
- Fundamental
- Price
- NVCR $12.04
- PZZA $40.47
- Analyst Decision
- NVCR Buy
- PZZA Buy
- Analyst Count
- NVCR 7
- PZZA 9
- Target Price
- NVCR $28.64
- PZZA $49.44
- AVG Volume (30 Days)
- NVCR 1.7M
- PZZA 2.5M
- Earning Date
- NVCR 10-30-2025
- PZZA 11-06-2025
- Dividend Yield
- NVCR N/A
- PZZA 4.77%
- EPS Growth
- NVCR N/A
- PZZA N/A
- EPS
- NVCR N/A
- PZZA 1.14
- Revenue
- NVCR $642,269,000.00
- PZZA $2,086,399,000.00
- Revenue This Year
- NVCR $9.54
- PZZA $4.45
- Revenue Next Year
- NVCR $5.70
- PZZA $0.93
- P/E Ratio
- NVCR N/A
- PZZA $35.37
- Revenue Growth
- NVCR 11.17
- PZZA N/A
- 52 Week Low
- NVCR $10.70
- PZZA $30.16
- 52 Week High
- NVCR $34.13
- PZZA $55.74
- Technical
- Relative Strength Index (RSI)
- NVCR 47.66
- PZZA 40.37
- Support Level
- NVCR $11.09
- PZZA $39.25
- Resistance Level
- NVCR $11.63
- PZZA $41.30
- Average True Range (ATR)
- NVCR 0.52
- PZZA 3.84
- MACD
- NVCR 0.05
- PZZA -0.42
- Stochastic Oscillator
- NVCR 86.51
- PZZA 15.87
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.